NFKB1 and cancer: When compared to other cancer types, a distinct activity pattern was also observed for NCI-H295R cells, in which several of the drugs were also active against other cancer cells, but they usually showed less activity or even no antiproliferative effect in cervical cancer cells (NF-kB) (Figure2B).